LifeVantage to Announce Second Quarter Fiscal Year 2022 Results on February 1, 2022

Rhea-AI Summary

LifeVantage Corporation (Nasdaq: LFVN) will announce its financial results for the second quarter ended December 31, 2021, on February 1, 2022, post-market close. A conference call for investors is scheduled for 2:30 PM MT (4:30 PM ET) the same day. Interested participants can join by dialing (877) 705-6003 or (201) 493-6725 for international callers. A replay will be available shortly after the call until February 8, 2022. LifeVantage focuses on nutrigenomics, offering products like Protandim® and Petandim®, with an emphasis on health and wellness.

Positive

• Scheduled release of financial results may indicate transparency.
• Conference call provides opportunity for investor engagement.

Negative

• None.

SALT LAKE CITY, Jan. 20, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its second quarter ended December 31, 2021, after the stock market closes on Tuesday, February 1, 2022. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 705-6003 from the U.S. or international callers can dial (201) 493-6725. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, February 8, 2022, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13726365, or (412) 317-6671 from international locations, and entering the confirmation code.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly here. The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+™, ProBio™, and Daily Wellness™ dietary supplements, TrueScience® is the Company's line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com

 

FAQ

When will LifeVantage release its financial results for Q2 2022?

LifeVantage will release its financial results for the second quarter on February 1, 2022, after the market closes.

What time is the LifeVantage conference call for Q2 2022 results?

The conference call is scheduled for 2:30 PM Mountain Time (4:30 PM Eastern Time) on February 1, 2022.

How can I participate in the LifeVantage conference call?

Participants can join by dialing (877) 705-6003 or (201) 493-6725 for international callers.

Is there a replay available for the LifeVantage conference call?

Yes, a replay will be available approximately two hours after the call and will last until February 8, 2022.

What is LifeVantage known for?

LifeVantage is known for its focus on nutrigenomics and offers a range of health and wellness products, including dietary supplements and nootropics.